OpenVSafe by OpenVAERS
Search V-safe

8K6-12745-50759

3 vaccinations 5 coded responses 27 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
606 / IL
Registered
2021-04-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-14
    Registered in v-safe
  3. 2021-04-14
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-14
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-04-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Muscle spasms — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Foot cramps
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Abdominal distension, Flatulence, Muscle spasms — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Foot cramps, gas, bloating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Nausea, Abdominal pain
    Adult check-in
  8. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Abdominal pain
    Adult check-in
  9. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Abdominal pain
    Adult check-in
  10. 2021-04-21
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-07-16
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-10-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-10-16
    Dose 3 — Pfizer-BioNTech
  17. 2021-10-16
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2021-10-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  19. 2021-10-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Nausea, Abdominal pain
    Adult check-in
  20. 2021-10-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2021-10-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2021-10-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  23. 2021-10-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-10-23
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-10-30
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-11-06
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-11-13
    Survey response — day 28, dose 3
    MedDRA: Chills, Nausea, Pyrexia — Feeling: Good · Be unable to do your normal daily activities
    Free text: Fever, chills, nausea
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-11-20
    Survey response — day 35, dose 3
    MedDRA: Abdominal pain upper, Antinuclear antibody increased, Headache, Productive cough, Pyrexia, SARS-CoV-2 test negative, Unevaluable event, White blood cell count increased — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Low grade fever, WBC 15.81, ANC 14.16, productive cough, headache, stomach cramps. COVID rapid test was negative. · Healthcare visit (other): Already scheduled visit with bloodwork.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-20
    Report sent to call center — day 35, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  30. 2021-11-27
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-12-01
  32. 2021-12-01
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  33. 2022-01-15
    Survey response — 3 months, dose 3
    MedDRA: Abdominal pain upper, Malaise, Reaction to previous exposure to any vaccine, Respiratory symptom, SARS-CoV-2 test negative, Thirst — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Unconfirmed COVID breakthrough infection. Negative rapid test, unable to get a PCR test because of shortages. Had same symptoms as with vaccine doses- stomach cramps, extreme thirst, plus upper respiratory symptoms. Son had an exposure at school.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-04-18
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Pfizer-BioNTech
22021-04-14Pfizer-BioNTech
32021-10-16Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-15

Systemic reaction (other): Foot cramps

2021-04-16

Systemic reaction (other): Foot cramps, gas, bloating

Release 10 — day 28, dose 3

2021-11-13

Symptoms: Fever, chills, nausea

Release 10 — day 35, dose 3

2021-11-20

Symptoms: Low grade fever, WBC 15.81, ANC 14.16, productive cough, headache, stomach cramps. COVID rapid test was negative.
Healthcare visit (other): Already scheduled visit with bloodwork.

Release 10 — 3 months, dose 3

2022-01-15

Symptoms: Unconfirmed COVID breakthrough infection. Negative rapid test, unable to get a PCR test because of shortages. Had same symptoms as with vaccine doses- stomach cramps, extreme thirst, plus upper respiratory symptoms. Son had an exposure at school.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDAbdominal pain upper · · ✓
SDAntinuclear antibody increased · · ✓
SDChills · · ✓
SDHeadache · · ✓
SDMalaise · · ✓
SDNausea · · ✓
SDProductive cough · · ✓
SDPyrexia · · ✓
SDReaction to previous exposure to any vaccine · · ✓
SDRespiratory symptom · · ✓
SDSARS-CoV-2 test negative · · ✓
SDThirst · · ✓
SDWhite blood cell count increased · · ✓
SROAbdominal distension ✓ ✓ ✓
SROFlatulence ✓ ✓ ✓
SROMuscle spasms ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release